AHRQ Effective Health Care Program Posts Two Studies on the Treatment of COPD
Outcomes Associated with Tiotropium Use in Patients with COPD measures the safety and effectiveness of the use of tiotropium (a medication sold as Spiriva that opens air passages to the lungs) when taken with inhaled corticosteroids (used to regulate inflammation), and long-acting beta-agonists (used to relax bronchial muscles). The combination resulted in a 40 percent reduction in deaths from the disease as well as a 16 percent reduction in bronchial irritations and 22 percent fewer COPD-related hospitalizations. Other medication combinations did not yield the same improvements.
Mortality Risk in COPD Patients Using Theophylline (PDF File) (PDF Help) evaluates outcomes associated with six treatment regimens, including inhaled corticosteroids, long-acting beta-agonists, and ipratropium, with theophylline compared to each regimen without theophylline in patients with COPD. Patients receiving regimens that included theophylline had slightly increased risks of death, bronchial irritations, and COPD-related hospitalizations.
Both studies were conducted by researchers from the University of Illinois at Chicago and were funded by AHRQ’s Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program. Print copies are available by sending an e-mail to ahrqpubs@ahrq.gov.
Related posts:
- Chicken Little, COPD, Advair Review suggests asthma drugs safe, effective in COPD Previous research...
- No evidence inhaled corticosteroids increase osteoporosis risk A study has found that treatment with inhaled corticosteroids...
- Management Program Improves Care for COPD Medscape Today A simple management program, featuring a brief...
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions COPD is prevalent in Western society and its incidence...
- Inhaled Corticosteroids Boost Pneumonia Risk in COPD - Benefits should be weighed against downside, experts say The use of inhalers containing corticosteroids to treat chronic...
Related posts brought to you by Yet Another Related Posts Plugin.
January 7, 2010
Tags: spiriva study, theophylline study, treatments for COPD Posted in: COPD - Medications and Treatment
One Response
tom cullen - January 8, 2010
About 5 years ago I had to argue with(insist) my pulmonoligist to get an Rx for Spiriva. My personal adjustment to my Rx therapy is: Spiriva and Advair(250/50) in the a.m. No second dose of Advair-I believe the twice a day dosage of Advair was either inducing or worsening my exacerbations, but the one dose therapy does help my respiratory function. Admittedly this is not very scientific but it works for me!
Leave a Reply